The current valuation score of Surrozen Inc is 8.23, ranking 170 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.66, which is -60.10% below the recent high of -0.26 and -225.97% above the recent low of -2.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.